Can a home device keep cirrhosis patients out of the hospital?
NCT ID NCT02457988
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a home monitoring kit (measuring blood pressure, weight, and pulse) plus care coordination could reduce hospital readmissions in people with cirrhosis. It enrolled 120 patients with serious complications like fluid buildup or confusion. The trial was terminated early, so the findings are limited.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Vivify Kit (home telemonitoring device)
- What this could lead to
- If successful, this approach could help manage cirrhosis at home and reduce hospital readmissions.
- What could go wrong
- The trial was terminated early, so results are limited. It is a small, early-phase study, and the device may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UCLA Center for Inflammatory Bowel Diseases
Los Angeles, California, 90095, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can everyday drugs shield the liver from Cirrhosis's worst threats?
- Could a yellow tinge predict dangerous hospital infections?
- Muscle quality on MRI may foretell liver transplant success
- Melatonin may ease sleep and brain fog in liver disease — a trial puts it to the test
- Heart scans could uncover silent damage in liver patients awaiting transplant
- Could the Body's largest vein replace a Hard-to-Reach one for liver pressure checks?